Shandong Boyuan Pharmaceutical & Chemical Co Ltd. Stock Analysis 301617.SZ

Shandong Boyuan Pharmaceutical & Chemical Co. Ltd. engages in the research, development, production, and sales of fine chemicals. The company is headquartered in Weifang, Shandong and currently employs 748 full-time employees. The company went IPO on 2024-12-11. The firm's main businesses include organic iodides, inorganic iodides, precious metal catalysts and luminescent materials. The firm is also engaged in the research and development, production and sales of products including hexamethyldisilazane (HMDS), and based on its comprehensive resource utilization qualifications and process technology advantages, it carries out recycling business of materials containing iodine, precious metals, among others. The firm also provides customers with processing services such as precious metal catalysts and HMDS. The firm's products and services are widely used in the fields of medicine, chemicals, optoelectronic materials, feed, food, among others. The firm mainly conducts its businesses in the domestic market.